Open access · OA
via OpenAlex
MP278ASSOCIATIONS OF FGF-23 AND KLOTHO SERUM LEVELS WITH CARDIOVASCULAR RISK IN CHRONIC KIDNEY DISEASE PATIENTS
Anna Dudareva, Ludmila Yu. Milovanova, Mihail Brovko
Nephrology Dialysis Transplantation · 2016
Abstract
Introduction and Aims: The aim of the study was to identify the role of serum FGF-23 and Klotho as cardiovascular risk markers in chronic kidney disease (CKD) stage 1- 5D. Methods: The main group consisted of 130 CKD patients (67m / 63f, 20-65 yrs, average age 41 ± 6,7 years) Control group: 30 healthy volunteers matched by age and sex. All patients were observed in dynamic within 1 year. ELISA was used for serum FGF-23 and Klotho. The study was approved by the institutional ethical committee. Results: Dynamic of serum Klotho and FGF-23, when compared to serum phosphate and parathyroid hormone (PTH), resulted in its changed already from stage 3A of CKD whereas PTH and phosphorus - only from stage 4-5. We found also a negative relation between serum Klotho levels and pulse wave velocity (PVW) [r=-0,647;p<0,01]. Between serum FGF-23 level and PWV a positive correlation was found. A significant negative relation between serum Klotho levels and the degree of heart calcification [r=- 0,612; p<0,01] assessed by semiquantitative scale was obtained. Between FGF-23 serum levels and the degree of calcification a positive correlation was found [r=0,498; p<0,05]). Among the studied factors FGF-23 serum levels were strongly correlated with the myocardial remodeling[r=0,598; p<0,01]. According to the multiple regression analysis, left ventricular mass index was higher in patients with higher serum FGF-23, central systolic blood pressure (BP) and PWV. According to the ROC-analysis, the value of serum FGF-23 above 412 pg / ml, testified Left Ventricular Hypertrophy with 80% sensitivity and 76% specificity. According to the ROC-analysis, the values of serum Klotho below 487 pg/ml testified the PWV increasing with 80% sensitivity and 75% specificity.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/ndt/gfw188.34
- Canonical
- link ↗
- Fetched
- 2026-10-26 MST
Cite this
APA
Dudareva, A., Milovanova, L.Y., & Brovko, M. (2016). MP278ASSOCIATIONS OF FGF-23 AND KLOTHO SERUM LEVELS WITH CARDIOVASCULAR RISK IN CHRONIC KIDNEY DISEASE PATIENTS. <em>Nephrology Dialysis Transplantation</em>. https://doi.org/10.1093/ndt/gfw188.34
Vancouver
Dudareva A, Milovanova LY, Brovko M. MP278ASSOCIATIONS OF FGF-23 AND KLOTHO SERUM LEVELS WITH CARDIOVASCULAR RISK IN CHRONIC KIDNEY DISEASE PATIENTS. Nephrology Dialysis Transplantation. 2016. doi:10.1093/ndt/gfw188.34.
BibTeX
@article{anna2016MPASSO,
title = {MP278ASSOCIATIONS OF FGF-23 AND KLOTHO SERUM LEVELS WITH CARDIOVASCULAR RISK IN CHRONIC KIDNEY DISEASE PATIENTS},
author = {Anna Dudareva and Ludmila Yu. Milovanova and Mihail Brovko},
journal = {Nephrology Dialysis Transplantation},
year = {2016},
doi = {10.1093/ndt/gfw188.34},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Endocrinology 2024
Open access · CC-BY
Nonlinear relationship between serum Klotho and chronic kidney disease in US adults with metabolic syndrome
BioMed Research International 2018
Open access · CC-BY
Correlation between Soluble α-Klotho and Renal Function in Patients with Chronic Kidney Disease: A Review and Meta-Analysis
PLoS ONE 2013
Open access · CC-BY
A Decreased Level of Serum Soluble Klotho Is an Independent Biomarker Associated with Arterial Stiffness in Patients with Chronic Kidney Disease
国际移植与血液净化杂志 2017
Citation only
Relation of angiosteosis in chronic kidney disease patients with fibroblast growth factor 23-Klotho axis
Chin J Postgrad Med 2014
Citation only
The level of serum Klotho in patients with chronic kidney disease and its relationship with renal function
PubMed 2017
Preprint